These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10880915)

  • 1. [Should Helicobacter pylori infection be taken into account in the use of nonsteroidal anti-inflammatory agents?].
    Bretagne JF; Pagenault M; Bourienne A; Heresbach D
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C48-64. PubMed ID: 10880915
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dyspepsia and non-steroidal anti-inflammatory agents: not everything is an ulcer].
    Lanas A; Arroyo MT
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():25-30. PubMed ID: 11968331
    [No Abstract]   [Full Text] [Related]  

  • 3. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F; De Luca L; Graham DY
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):775-85. PubMed ID: 11566040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
    Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
    Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NSAIDs, Helicobacter pylori, and Pandora's Box.
    Graham DY
    N Engl J Med; 2002 Dec; 347(26):2162-4. PubMed ID: 12501230
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cyclooxygenase-2 and gastroduodenal lesions. Any relationship with Helicobacter pylori ? A systematic review].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 2003 Apr; 120(14):550-8. PubMed ID: 12724068
    [No Abstract]   [Full Text] [Related]  

  • 7. Helicobacter pylori and perforated peptic ulcer prevalence of the infection and role of non-steroidal anti-inflammatory drugs.
    Gisbert JP; Legido J; García-Sanz I; Pajares JM
    Dig Liver Dis; 2004 Feb; 36(2):116-20. PubMed ID: 15002818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of NSAID-related gastroduodenal mucosal injury.
    Aalykke C; Lauritsen K
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):705-22. PubMed ID: 11566036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis against non-steroidal anti-inflammatory drug-associated ulcers and erosions].
    Miyake K; Sakamoto C
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():577-82. PubMed ID: 11979850
    [No Abstract]   [Full Text] [Related]  

  • 10. [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].
    Lamarque D
    Bull Cancer; 2004 May; 91 Spec No():S117-24. PubMed ID: 15239340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Helicobacter pylori, cyclooxygenase-2 and gastric cancer].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 2003 Feb; 120(5):189-93. PubMed ID: 12605827
    [No Abstract]   [Full Text] [Related]  

  • 12. [Are COX-2 inhibitors truly able to prevent NSAIDs-associated ulcer?].
    Nishida T; Tsujii M; Tsuji S
    Nihon Rinsho; 2004 Mar; 62(3):561-5. PubMed ID: 15038104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of COX-2].
    Tatsuguchi A; Sakamoto C
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():207-10. PubMed ID: 11979779
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gastrointestinal complications of nonsteroidal anti-inflammatory drugs and low-dose aspirin].
    Thiéfin G
    Gastroenterol Clin Biol; 2003 May; 27(5):498-510. PubMed ID: 12843912
    [No Abstract]   [Full Text] [Related]  

  • 15. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Consensus development conference on Helicobacter pylori. Revised conclusions and recommendations of the Working group (1999)].
    Gastroenterol Clin Biol; 1999 Oct; 23(10 Pt 2):C95-104. PubMed ID: 10880918
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drug-induced gastroduodenal toxicity and Helicobacter pylori.
    Wardi J; Shirin H
    Isr Med Assoc J; 2003 Mar; 5(3):195-7. PubMed ID: 12725142
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
    Weilert F; Smith AC; Stokes PL
    N Engl J Med; 1998 Jul; 339(5):349; author reply 350-1. PubMed ID: 9696649
    [No Abstract]   [Full Text] [Related]  

  • 19. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.
    Wu CY; Wu MS; Chen CJ; Li MC; Lin JT; Chen GH
    J Clin Gastroenterol; 2005 Jan; 39(1):50-5. PubMed ID: 15599211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Introduction.
    Hawkey CJ
    Am J Med; 2001 Jan; 110(1A):1S-3S. PubMed ID: 11165986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.